BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5308224)

  • 1. Neutron therapy of cancer: biochemical and biophysical aspects. ANL-7409.
    Frigerio NA; Shaw MJ; Nellans HN
    ANL Rep; 1967; ():169-72. PubMed ID: 5308224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of dimercaptocarborane derivatives in neutron capture therapy].
    Spryshkova RA; Bratsev VA; Shabalkin IP
    Med Radiol (Mosk); 1980 Nov; 25(11):46-50. PubMed ID: 7442488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current problems of neutron radiobiology].
    Obaturov GM; Sokolov VA; Ul'ianenko SE; Tsyb TS
    Radiats Biol Radioecol; 1997; 37(4):475-81. PubMed ID: 9599600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accumulation of carborane-series compounds in animal tissues during neutron-capture therapy].
    Spryshkova RA; Brattsev VA; Sherman TL; Stanko VI
    Med Radiol (Mosk); 1981 Jul; 26(7):51-5. PubMed ID: 7289807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of clinical use of the results of experimental studies of neutron-capture therapy based on Li6].
    Riabukhin IuS; Letov VN; Ivanov VN
    Med Radiol (Mosk); 1973 Jul; 18(7):41-8. PubMed ID: 4756302
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative biophysical aspects of responses of tumours and normal tissues to ionizing radiations.
    Barendsen GW
    Curr Top Radiat Res Q; 1973 Oct; 9(1):101-8. PubMed ID: 4800957
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutron scattering. The case for neutron sources.
    Keimer B; Sackmann E; Withers PJ
    Science; 2002 Oct; 298(5593):543. PubMed ID: 12386318
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved monitoring system of neutron flux during boron-neutron capture therapy.
    Harasawa S; Nakamoto A; Hayakawa Y; Egawa J; Aizawa O; Nozaki T; Minobe T; Hatanaka H
    Radiat Res; 1981 Oct; 88(1):187-93. PubMed ID: 7302126
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of boronated tetracycline antibiotic derivatives (T 2 B 2 ) as the boron-10 carrier in neutron capture therapy.
    Gillchriest WC; Shaw DH
    Oncology; 1973; 27(2):97-104. PubMed ID: 4701584
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of boron nanocapsules for neutron capture therapy.
    Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First neutron generation in the BINP accelerator based neutron source.
    Bayanov B; Burdakov A; Chudaev V; Ivanov A; Konstantinov S; Kuznetsov A; Makarov A; Malyshkin G; Mekler K; Sorokin I; Sulyaev Y; Taskaev S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S285-7. PubMed ID: 19375928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutron beam design, development, and performance for neutron capture therapy. Proceedings of an international symposium. March 29-31, 1989, Cambridge, Massachusetts.
    Basic Life Sci; 1990; 54():1-353. PubMed ID: 1980058
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor targeting agents for neutron capture therapy.
    Soloway AH; Alam F; Barth RF; Anisuzzaman AK; Bapat BV
    Basic Life Sci; 1990; 54():37-47. PubMed ID: 2268247
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
    Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
    Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neutron producing target for BINP accelerator-based neutron source.
    Bayanov B; Kashaeva E; Makarov A; Malyshkin G; Samarin S; Taskaev S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S282-4. PubMed ID: 19376729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New compounds for neutron capture therapy (NCT) and their significance.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):764-70. PubMed ID: 6393459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of an accelerator-based neutron source for neutron capture therapy.
    Terlizzi R; Colonna N; Colangelo P; Maiorana A; Marrone S; Rainò A; Tagliente G; Variale V
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S292-5. PubMed ID: 19406649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long range effects of neutron capture therapy of cancer in mice--II. Dose effect.
    Farr LE; Konikowski T
    Int J Nucl Med Biol; 1978 Mar; 5(1):3-10. PubMed ID: 659058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.